Abstract
Hydroxyurea (HU) is used as a therapy in sickle cell anemia (SCA). Many studies have established that HU improves patient quality of life by reducing symptoms. However, the effect of HU on erythrocytes is not well-described. We evaluated several parameters related to oxidative stress and total lipid content of erythrocytes in patients with SCA. The patient cohort consisted of 7 SCA patients treated with HU, 17 untreated SCA patients, and 15 healthy subjects. Erythrocytes from patients with SCA displayed increased oxidative stress relative to the control group, including higher thiobarbituric acid reactive substances (TBARS), Fe3+ content, and osmotic fragility, and decreased total cholesterol. We observed that treatment of SCA patients with HU increased Fe3+ content and activity of glutathione peroxidase, and decreased glutathione reductase activity, glutathione levels, total cholesterol, and phospholipid content comaperaded to patients untreated with HU. Thus, HU alters biochemical characteristics of erythrocytes; future studies will determine whether they are beneficial or not.
Similar content being viewed by others
References
Di Nuzzo DV, Fonseca SF (2004) Sickle cell disease and infection. J Pediatr 80:347–354
Pauling L, Itano HA, JE SJS, Wells IC (1949) Sickle cell anemia a molecular disease. Science 110:543–548
Peterson CM, Tsairis P, Onishi A, Lu YS, Grady R (1974) Sodium cyanate induced polyneuropathy in patients with sickle-cell disease. Ann Intern Med 81:152–158
Bunn HF (1997) Pathogenesis and treatment of sickle cell disease. N Engl J Med 337:762–769
Safo MK, Abdulmalik O, Danso-Danquah R, Burnett JC, Nokuri S, Joshi GS, Musayev FN, Asakura T, Abraham DJ (2004) Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds. J Med Chem 47:4665–4676
El Nemer W, Wautier MP, Rahuel C, Gane P, Hermand P, Galacteros F, Wautier JL, Cartron JP, Colin Y, Le Van Kim C (2007) Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: role in adhesion of sickle red blood cells to endothelial cells. Blood 109:3544–3551
Taylor JG, Nolan VG, Mendelsohn L, Kato GJ, Gladwin MT, Steinberg MH (2008) Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One 3:e2095
Dailly E, Urien S, Barre J, Reinert P, Tillement JP (1998) Role of bilirubin in the regulation of the total peroxyl radical trapping antioxidant activity of plasma in sickle cell disease. Biochem Biophys Res Commun 248:303–306
Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, Ginsburg H (2004) Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 34:163–189
Steinberg MH (1999) Management of sickle cell disease. New Engl J Med 340:1021–1030
King SB (2003) The nitric oxide producing reactions of hydroxyurea. Curr Med Chem 10(6):437–452
Ware RE (2010) How I use hydroxyurea to treat young patients with sickle cell anemia. Blood 115:5300–5311
Gladwin MT, Shelhamer JH, Ognibene FP, Pease-Fye ME, Nichols JS, Link B, Patel DB, Jankowski MA, Pannell LK, Schechter AN, Rodgers GP (2002) Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol 116:436–444
Olujohungbe A, Cinkotai KI, Yardumian A (1998) Hydroxyurea therapy for sickle cell disease in Britain: disappointing recruitment despite promising results. BMJ 316:1689
Lanaro C, Franco-Penteado CF, Albuqueque DM, Saad ST, Conran N, Costa FF (2009) Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J Leukoc Biol 85:235–242
Steinberg MH, Dreiling BJ, Morrison FS, Necheles TF (1973) Mild sickle cell disease. Clinical and laboratory studies. Jama 224:317–321
Schacter L, Warth JA, Gordon EM, Prasad A, Klein BL (1988) Altered amount and activity of superoxide dismutase in sickle cell anemia. FASEB J 2:237–243
Costa H, Santos R, Lima E (2006) A simple automated procedure for thiol measurement in human serum samples. J Bras Patol Med Lab 42:345–350
Adams PC (1995) Determining iron content in foods by spectrophotometry. Filtr Resid 72:649–651
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126
Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–3523
Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888
Flohe L, Gunzler WA, Schock HH (1973) Glutathione peroxidase: a selenoenzyme. FEBS Lett 32:132–134
Nakamura O, Hosada S (1974) Purification and properties of rat liver glutathione peroxidase. BiochimBiophysActa 358:251–261
Racker E (1955) Glutathione reductase from bakers’ yeast and beef liver. J Biol Chem 217:855–856
Rose HG, Oklander M (1965) Improved procedure for the extraction of lipids from human erythrocytes. J Lipid Res 6:428–431
Vokurkova M, Novakova O, Dobesova Z, Kunes J, Zicha J (2005) Relationships between membrane lipids and ion transport in red blood cells of Dahl rats. Life Sci 77:1452–1464
Chen PS, Toribara TY, Warner H (1956) Microdetermination of phosphorus. Anal Chem 28:1756–1758
Higgins J (1987) Separation and analysis of membrane lipid components. In: Findlay J, Evans W (eds) Biological membranes: a practical approach. IRL Press, Oxford, pp 103–107
Ministry of Health. Clinical protocol and therapeutic guidelines-sickle cell disease. Concierge n° 55, de 29 de January 2010
Das SK, Nair RC (1980) Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Br J Haematol 44:87–92
Al-Naama LM, Hassan MK, Mehdi JK (2015) Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia. Qatar Med J 2015:14
Spiteller P, Spiteller G (1998) Strong dependence of the lipid peroxidation product spectrum whether Fe2+/O2 or Fe3+/O2 is used as oxidant. Biochim Biophys Acta 1392:23–40
Magalhães SM (2011) Oxidative status in sickle cell anemia. Rev Bras Hematol Hemoter 33:177–178
Fatima M, Kesharwani RK, Misra K, Rizvi SI (2013) Protective effect of theaflavin on erythrocytes subjected to in vitro oxidative stress. Biochem Res Int 2013:649759
Daak AA, Ghebremeskel K, Mariniello K, Attallah B, Clough P, Elbashir MI (2013) Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients. Prostaglandins Leukot Essent Fat Acids 89:305–311
Malec J, Przybyszewski WM, Grabarczyk M, Sitarska E (1984) Hydroxyurea has the capacity to induce damage to human erythrocytes which can be modified by radical scavengers. Biochem Biophys Res Commun 120:566–573
Iyamu EW, Fasold H, Roa D, del Pilar AM, Asakura T, Turner EA (2001) Hydroxyurea-induced oxidative damage of normal and sickle cell hemoglobins in vitro: amelioration by radical scavengers. J Clin Lab Anal 15(1):1–7
Johnson RM, Goyette G Jr, Ravindranath Y, Ho YS (2005) Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. Free Radic Biol Med 39:1407–1417
Cho CS, Kato GJ, Yang SH, Bae SW, Lee JS, Gladwin MT, Rhee SG (2010) Hydroxyurea-induced expression of glutathione peroxidase 1 in red blood cells of individuals with sickle cell anemia. Antioxid Redox Signal 13:1–11
Liu ZQ, Shan HY (2006) Cholesterol, not polyunsaturated fatty acids, is target molecule in oxidation induced by reactive oxygen species in membrane of human erythrocytes. Cell Biochem Biophys 45(2):185–193. https://doi.org/10.1385/cbb:45:2:185
Leitner GC, Neuhauser M, Weigel G, Kurze S, Fischer MB, Hocker P (2001) Altered intracellular purine nucleotides in gamma-irradiated red blood cell concentrates. Vox Sang 81:113–118
Arashiki N, Takakuwa Y (2017) Maintenance and regulation of asymmetric phospholipid distribution in human erythrocyte membranes: implications for erythrocyte functions. Curr Opin Hematol 24:167–172
Connor WE, Lin DS, Thomas G, Ey F, DeLoughery T, Zhu N (1997) Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia. J Lipid Res 38:2516–2528
Acknowledgments
We thank the Hemominas Foundation for providing samples and archives. We are thankful to Dr. Kenneth Peterson (KUMC) for the helpful evaluation of the manuscript.
Funding
This work was supported by FAPEMIG (Fundação de Amparo a Pesquisa do Estado de Minas Gerais), CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), and CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico).
Author information
Authors and Affiliations
Contributions
Conceived and designed the experiments: MBP, DRR, VFC, LAB, and HLS. Performed the experiments: COR. Analyzed the data: COR, MBP, DRR, VFC, HLS, and LAB. Contributed reagents/materials/analysis tools: ARB, SSC, MBP, HLS, and LAB. Wrote the paper: COR, VFC, HLS, and LAB.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Renó, C.O., Barbosa, A.R., de Carvalho, S.S. et al. Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea. Ann Hematol 99, 937–945 (2020). https://doi.org/10.1007/s00277-020-03987-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-020-03987-7